$PMDI
PSYCHEMEDICS CORP

2024 Q4 Form 10-Q Financial Statement

#000117184324006286 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $5.175M
YoY Change -9.27%
Cost Of Revenue $3.136M
YoY Change -13.2%
Gross Profit $2.039M
YoY Change -2.49%
Gross Profit Margin 39.4%
Selling, General & Admin $2.462M
YoY Change -15.77%
% of Gross Profit 120.75%
Research & Development $172.0K
YoY Change -37.45%
% of Gross Profit 8.44%
Depreciation & Amortization $293.0K
YoY Change -34.89%
% of Gross Profit 14.37%
Operating Expenses $2.634M
YoY Change -17.64%
Operating Profit -$595.0K
YoY Change -46.25%
Interest Expense -$1.000K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$11.00K
YoY Change
Pretax Income -$606.0K
YoY Change -45.26%
Income Tax -$71.00K
% Of Pretax Income
Net Earnings -$535.0K
YoY Change -74.51%
Net Earnings / Revenue -10.34%
Basic Earnings Per Share -$0.09
Diluted Earnings Per Share -$0.09
COMMON SHARES
Basic Shares Outstanding 5.894M 5.824M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.405M
YoY Change 2.55%
Cash & Equivalents $1.405M
Short-Term Investments
Other Short-Term Assets $1.302M
YoY Change -14.34%
Inventory
Prepaid Expenses
Receivables $3.325M
Other Receivables $15.00K
Total Short-Term Assets $6.047M
YoY Change -23.18%
LONG-TERM ASSETS
Property, Plant & Equipment $3.283M
YoY Change -39.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $505.0K
YoY Change -37.58%
Total Long-Term Assets $3.788M
YoY Change -39.22%
TOTAL ASSETS
Total Short-Term Assets $6.047M
Total Long-Term Assets $3.788M
Total Assets $9.835M
YoY Change -30.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $994.0K
YoY Change 21.66%
Accrued Expenses $1.816M
YoY Change -43.39%
Deferred Revenue
YoY Change
Short-Term Debt $418.0K
YoY Change
Long-Term Debt Due $77.00K
YoY Change -74.5%
Total Short-Term Liabilities $3.793M
YoY Change -29.56%
LONG-TERM LIABILITIES
Long-Term Debt $61.00K
YoY Change -20.78%
Other Long-Term Liabilities $535.0K
YoY Change -55.79%
Total Long-Term Liabilities $596.0K
YoY Change 674.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.793M
Total Long-Term Liabilities $596.0K
Total Liabilities $4.389M
YoY Change -34.25%
SHAREHOLDERS EQUITY
Retained Earnings -$18.82M
YoY Change 18.92%
Common Stock $35.99M
YoY Change 2.89%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.08M
YoY Change
Treasury Stock Shares
Shareholders Equity $5.446M
YoY Change
Total Liabilities & Shareholders Equity $9.835M
YoY Change -30.27%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$535.0K
YoY Change -74.51%
Depreciation, Depletion And Amortization $293.0K
YoY Change -34.89%
Cash From Operating Activities $263.0K
YoY Change -127.4%
INVESTING ACTIVITIES
Capital Expenditures $14.00K
YoY Change -53.33%
Acquisitions
YoY Change
Other Investing Activities $16.00K
YoY Change -260.0%
Cash From Investing Activities $2.000K
YoY Change -105.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -294.0K
YoY Change 320.0%
NET CHANGE
Cash From Operating Activities 263.0K
Cash From Investing Activities 2.000K
Cash From Financing Activities -294.0K
Net Change In Cash -29.00K
YoY Change -97.29%
FREE CASH FLOW
Cash From Operating Activities $263.0K
Capital Expenditures $14.00K
Free Cash Flow $249.0K
YoY Change -125.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Entity File Number
EntityFileNumber
1-13738
dei Entity Registrant Name
EntityRegistrantName
PSYCHEMEDICS CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
58-1701987
dei Entity Address Address Line1
EntityAddressAddressLine1
5220 Spring Valley Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75254
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
527-7424
dei Security12b Title
Security12bTitle
Common stock. $0.005 par value
dei Trading Symbol
TradingSymbol
PMD
dei Security Exchange Name
SecurityExchangeName
NASDAQ
pmd Other Nonoperating Expense Settlement
OtherNonoperatingExpenseSettlement
500000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11000 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5894461
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1964000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
64000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3687000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1136000 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
18000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
6805000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23633000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3061000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
632000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1828000 usd
CY2024Q3 us-gaap Assets
Assets
9835000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3325000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1302000 usd
CY2024Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
15000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
6047000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21907000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2236000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
505000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
959000 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000806517
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1405000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
52000 usd
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
88000 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0 usd
CY2023Q4 us-gaap Assets
Assets
12326000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
994000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
752000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1816000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2604000 usd
CY2024Q3 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
418000 usd
CY2023Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
0 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
77000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
305000 usd
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
28000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
0 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
460000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1048000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3793000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4709000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
535000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
945000 usd
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
61000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0 usd
CY2024Q3 us-gaap Liabilities
Liabilities
4389000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5654000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
873000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
873000
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6563000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6474000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5895000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5806000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
32000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
32000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
35953000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
35129000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18823000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16773000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
668000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
668000
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
10082000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10082000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1634000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1634000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
5446000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6672000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9835000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12326000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5175000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5704000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
15260000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17100000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3136000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3613000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9547000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10745000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
2039000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
2091000 usd
us-gaap Gross Profit
GrossProfit
5713000 usd
us-gaap Gross Profit
GrossProfit
6355000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1882000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2200000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5261000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5291000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
580000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
723000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1943000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2258000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
172000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
275000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
570000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
859000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
2634000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
3198000 usd
us-gaap Operating Expenses
OperatingExpenses
7774000 usd
us-gaap Operating Expenses
OperatingExpenses
8408000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-595000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1107000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2061000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2053000 usd
CY2024Q3 pmd Other Nonoperating Expense Settlement
OtherNonoperatingExpenseSettlement
-0 usd
CY2023Q3 pmd Other Nonoperating Expense Settlement
OtherNonoperatingExpenseSettlement
-0 usd
pmd Other Nonoperating Expense Settlement
OtherNonoperatingExpenseSettlement
2000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-509000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-606000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1107000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2076000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2562000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-71000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
992000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-26000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
647000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-535000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2099000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2050000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3209000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5894000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5755000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5827000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5718000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
5741000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2024Q3 pmd Share Based Payment Arrangement Increase For Tax Withholding Obligation
ShareBasedPaymentArrangementIncreaseForTaxWithholdingObligation
12000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
228000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-535000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
5446000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6672000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
pmd Share Based Payment Arrangement Increase For Tax Withholding Obligation
ShareBasedPaymentArrangementIncreaseForTaxWithholdingObligation
25000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
799000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2050000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
5446000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
9127000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
401000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2099000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
7429000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
10771000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
54000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
721000 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
799000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3209000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
7429000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2050000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3209000 usd
pmd Depreciation And Amortization Excluding Rou Asset Amortization
DepreciationAndAmortizationExcludingRouAssetAmortization
918000 usd
pmd Depreciation And Amortization Excluding Rou Asset Amortization
DepreciationAndAmortizationExcludingRouAssetAmortization
1394000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
750000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
701000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
698000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
824000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
721000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-362000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
857000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-519000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
388000 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-3000 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
43000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
242000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
369000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-870000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-797000 usd
pmd Increase Decrease In Accrued Expenses And Accrued Income Taxes
IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes
-788000 usd
pmd Increase Decrease In Accrued Expenses And Accrued Income Taxes
IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes
-731000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-90000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2142000 usd
pmd Payments For Proceeds From Other Assets
PaymentsForProceedsFromOtherAssets
-95000 usd
pmd Payments For Proceeds From Other Assets
PaymentsForProceedsFromOtherAssets
24000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
108000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
31000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
32000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
34000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-164000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
267000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-55000 usd
pmd Payments Of Equipment Financing
PaymentsOfEquipmentFinancing
228000 usd
pmd Payments Of Equipment Financing
PaymentsOfEquipmentFinancing
220000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
8000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
-0 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
-0 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
799000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-503000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1074000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-559000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3380000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1964000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4750000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1405000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1370000 usd
us-gaap Interest Paid Net
InterestPaidNet
16000 usd
us-gaap Interest Paid Net
InterestPaidNet
14000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
651000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
874000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
86000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
91000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
pmd Stockholders Equity Reverse Stock Split Cash Per Share For Rounding
StockholdersEquityReverseStockSplitCashPerShareForRounding
2.35
CY2024Q3 us-gaap Cash
Cash
1400000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
228000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
401000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
799000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
721000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
512000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.32
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y8M12D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
105000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.4
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
50000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
14.7
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.23
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
566000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.05
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7M6D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
112000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.73
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y9M18D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
605000
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
712000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
605000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
712000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
959000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
995000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039 pure
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M
CY2024Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
150000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
628000 usd
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
88000 usd
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
89000 usd
CY2024Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.09 pure
CY2024Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y10M24D
CY2024Q3 pmd Finance Lease Expense
FinanceLeaseExpense
3000 usd
pmd Finance Lease Expense
FinanceLeaseExpense
3000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5175000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5704000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
15260000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17100000 usd

Files In Submission

Name View Source Status
0001171843-24-006286-index-headers.html Edgar Link pending
0001171843-24-006286-index.html Edgar Link pending
0001171843-24-006286.txt Edgar Link pending
0001171843-24-006286-xbrl.zip Edgar Link pending
ex_742600.htm Edgar Link pending
ex_742601.htm Edgar Link pending
ex_742602.htm Edgar Link pending
ex_742603.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pmd-20240930.xsd Edgar Link pending
pmd20240930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pmd-20240930_cal.xml Edgar Link unprocessable
pmd-20240930_def.xml Edgar Link unprocessable
pmd-20240930_lab.xml Edgar Link unprocessable
pmd-20240930_pre.xml Edgar Link unprocessable
pmd20240930_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable